Track topics on Twitter Track topics that are important to you
Glucagon like peptide1 GLP1 agonists is the agonists of the GLP1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide1 GLP1 Agonists market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export import
Key manufacturers manufacturing sites, capacity and production, product specifications etc.
Average market price by SUK
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Major applications as follows:
Regional market size, production data and export import:
Middle East AfricaNEXT ARTICLE